Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...

Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in liver sinusoidal endothelial cells - key cells ...

Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an ...

Transaction is Hopewell’s first commercial license of proprietary lipid nanoparticles (LNPs)Hopewell’s LNPs are the preferred ...

Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in ​its largest deal since 2020, the ​biopharma company said on ​Monday.

Madrigal Pharmaceuticals said on Wednesday it has entered into a global licensing deal with China-based Suzhou Ribo Life Science for six ​preclinical small interfering RNA programs to treat a ‌type of ...

The federal government is intensifying efforts in cancer prevention, screening, and treatment through new national policies, expanded vaccination, upgraded facilities, and free nationwide screening ...

By Christy Santhosh Feb 23 (Reuters) - Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in its largest deal since 2020, the biopharma company said on Monday, as it looks to ...

Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help distinguish gallbladder cancer from benign conditions, offering a potential ...

GRAIL, however, highlighted a favorable trend toward fewer Stage III-IV cancers in a pre-specified group of 12 deadly cancers ...

Colorectal cancer is the second leading cause of death from cancer in the U.S. Between 2012 and 2021, more colorectal cancer ...

Chronic hepatitis B is a viral disease that affects the liver and greatly increases the risks of liver cirrhosis and ...